{"id":"W4415147299","doi":"10.1111/jdv.70080","title":"Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada); Probity Medical Research; Alberta Barley; University of Toronto","funders":"Galderma","keywords":"Atopic dermatitis; Extension (predicate logic); MEDLINE; Dupilumab; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002768216,0.0009157507,0.001818944,0.0003328254,0.000494802,0.0008040564,0.0006141376,0.001095709,0.004078593],"category_scores_gemma":[0.001212407,0.0003114729,0.001571173,0.0002526902,0.0004525576,0.0009220449,0.0004139734,0.002085756,0.001218896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005802786,"about_ca_system_score_gemma":0.000815387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003881175,"about_ca_topic_score_gemma":0.0007996872,"domain_scores_codex":[0.9993312,0.0002932101,0.00005180201,0.0001146095,0.0001044544,0.0001046409],"domain_scores_gemma":[0.9984474,0.0001955394,0.0004330014,0.0001994164,0.0001486417,0.0005760404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8411282,0.04351007,0.02306838,0.0006175975,0.001803378,0.0003740599,0.0002126239,0.0006783399,0.01820942,0.0001078848,0.002510754,0.06777931],"study_design_scores_gemma":[0.4480613,0.4085216,0.1300822,0.0001258816,0.001506448,0.0005988588,0.00008016876,0.001320797,0.003265596,0.0002013723,0.006188157,0.00004760335],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942603,0.001614885,0.0003317309,0.0001437577,0.00006427108,0.001209693,0.001142248,0.00005410975,0.001179067],"genre_scores_gemma":[0.991275,0.0009261969,0.0005739121,0.0004292173,0.0001864698,0.001757551,0.002641511,0.00001366335,0.002196529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004078593,"threshold_uncertainty_score":0.01463991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02983851589985237,"score_gpt":0.3435051652012456,"score_spread":0.3136666493013933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}